Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.03
-0.26 (-0.76%)
At close: Nov 14, 2025, 4:00 PM EST
34.25
+0.22 (0.65%)
After-hours: Nov 14, 2025, 7:40 PM EST
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts that cover HRMY stock have a consensus rating of "Strong Buy" and an average price target of $50.44, which forecasts a 48.22% increase in the stock price over the next year. The lowest target is $36 and the highest is $70.
Price Target: $50.44 (+48.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 6 | 6 |
| Buy | 5 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $36 → $39 | Buy | Maintains | $36 → $39 | +14.60% | Nov 6, 2025 |
| UBS | UBS | Strong Buy Maintains $50 → $43 | Strong Buy | Maintains | $50 → $43 | +26.36% | Oct 15, 2025 |
| Mizuho | Mizuho | Buy Maintains $50 → $35 | Buy | Maintains | $50 → $35 | +2.85% | Sep 25, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $54 → $36 | Strong Buy | Maintains | $54 → $36 | +5.79% | Sep 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $55 | Strong Buy | Maintains | $70 → $55 | +61.62% | Sep 25, 2025 |
Financial Forecast
Revenue This Year
862.56M
from 714.73M
Increased by 20.68%
Revenue Next Year
1.00B
from 862.56M
Increased by 15.93%
EPS This Year
3.27
from 2.51
Increased by 30.15%
EPS Next Year
4.13
from 3.27
Increased by 26.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 915.0M | 1.1B | |||
| Avg | 862.6M | 1,000.0M | |||
| Low | 814.2M | 915.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.0% | 27.8% | |||
| Avg | 20.7% | 15.9% | |||
| Low | 13.9% | 6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.86 | 5.29 | |||
| Avg | 3.27 | 4.13 | |||
| Low | 2.24 | 2.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 53.9% | 62.0% | |||
| Avg | 30.1% | 26.3% | |||
| Low | -10.6% | -34.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.